Inflammatory bowel disease (IBD), which affects millions of people worldwide, includes two
separate diseases: Crohn's disease (CD) and ulcerative colitis (UC). Although the …

Background & Aims This narrative review provides an overview of the current regulation of
probiotics, with a focus on those used for the dietary management of medical conditions …

The prevalence of colorectal cancer (CRC) has markedly increased worldwide in the last
decade. Alterations of bile acid metabolism and gut microbiota have been reported to play …

Bile acid (BA) species and the gut microbiota (GM) contribute to intestinal mucosa
homeostasis. BAs shape the GM and, conversely, intestinal bacteria with bile salt hydrolase …

Background There is substantial demand for gut health products incorporating probiotics
and prebiotics. They are being delivered as ingredients in an increasing range of different …

Plants are regarded as a valuable and inexpensive source of new drug development, and a
variety of plant compounds are now being used in clinical trials to treat a variety of ailments …

Technological developments, including massively parallel DNA sequencing, gnotobiotics,
metabolomics, RNA sequencing and culturomics, have markedly propelled the field of …

The increase in concern from viable cells of probiotics specifically in acute inflammatory
conditions has led to the emergence of the concept of postbiotics as a safer alternative …

Purpose The aim of the present study was to develop an optimized Genkwanin (GKA)-
loaded self-nanoemulsifying drug delivery system (SNEDDS) formulation to enhance the …

Background Bruceine D (BD) is a major bioactive component isolated from the traditional
Chinese medicinal plant Brucea javanica which has been widely utilized to treat dysentery …